Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Trevi Therapeutics stock
Learn how to easily invest in Trevi Therapeutics stock.
Trevi Therapeutics Inc is a biotechnology business based in the US. Trevi Therapeutics shares (TRVI) are listed on the NASDAQ and all prices are listed in US Dollars. Trevi Therapeutics employs 23 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Trevi Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – TRVI – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Trevi Therapeutics stock price (NASDAQ: TRVI)Use our graph to track the performance of TRVI stocks over time.
Trevi Therapeutics shares at a glance
|Latest market close||$1.75|
|52-week range||$0.46 - $4.68|
|50-day moving average||$3.53|
|200-day moving average||$2.12|
|Wall St. target price||$10.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.28|
Buy Trevi Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Trevi Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Trevi Therapeutics price performance over time
|1 week (2022-09-19)||-42.81%|
|1 month (2022-08-26)||-51.39%|
|3 months (2022-06-24)||-21.17%|
|6 months (2022-03-25)||-16.67%|
|1 year (2021-09-24)||21.53%|
|2 years (2020-09-25)||-55.13%|
|3 years (2019-09-26)||4.2|
|5 years (2017-09-22)||N/A|
Trevi Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-31.17%|
|Return on equity TTM||-79.63%|
|Market capitalisation||$139.4 million|
TTM: trailing 12 months
Trevi Therapeutics share dividends
We're not expecting Trevi Therapeutics to pay a dividend over the next 12 months.
Trevi Therapeutics share price volatility
Over the last 12 months, Trevi Therapeutics's shares have ranged in value from as little as $0.46 up to $4.683. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Trevi Therapeutics's is 0.1999. This would suggest that Trevi Therapeutics's shares are less volatile than average (for this exchange).
Trevi Therapeutics overview
Trevi Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut. .
Trevi Therapeutics in the news
Is AVEO Pharmaceuticals (AVEO) Outperforming Other Medical Stocks This Year?
Frequently asked questionsWhat percentage of Trevi Therapeutics is owned by insiders or institutions?
Currently 4.991% of Trevi Therapeutics shares are held by insiders and 75.493% by institutions. How many people work for Trevi Therapeutics?
Latest data suggests 23 work at Trevi Therapeutics. When does the fiscal year end for Trevi Therapeutics?
Trevi Therapeutics's fiscal year ends in December. Where is Trevi Therapeutics based?
Trevi Therapeutics's address is: 195 Church Street, New Haven, CT, United States, 06510 What is Trevi Therapeutics's ISIN number?
Trevi Therapeutics's international securities identification number is: US89532M1018
More guides on Finder
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Ask an Expert